Literature DB >> 3028273

Superoxide-dependent redox cycling of citrate-Fe3+: evidence for a superoxide dismutaselike activity.

G Minotti, S D Aust.   

Abstract

Citrate-Fe3+, reportedly a physiological chelate, exhibits superoxide dismutaselike activity, as evidenced by the inhibition of xanthine oxidase-dependent cytochrome c reduction; the dismutation of xanthine oxidase-generated superoxide to hydrogen peroxide and oxygen, and the enhanced disproportionation of potassium superoxide. The catalytic activity of citrate-Fe3+ corresponds, on a molar basis, to 0.03% of that of copper- and zinc-containing superoxide dismutase. Although weak, this activity enables citrate-Fe3+ to inhibit superoxide and ADP-Fe3+ -dependent peroxidation of extracted microsomal lipids. Also, the dismutase activity of citrate-Fe3+ interferes with its ability to promote lipid peroxidation. It is proposed that chelation of Fe3+ by citrate may represent a protective mechanism against the deleterious consequences of superoxide generation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3028273     DOI: 10.1016/0003-9861(87)90659-x

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  4 in total

1.  Periplasmic superoxide dismutases in Aquaspirillum magnetotacticum.

Authors:  K A Short; R P Blakemore
Journal:  Arch Microbiol       Date:  1989       Impact factor: 2.552

Review 2.  Redox cycling of iron and lipid peroxidation.

Authors:  G Minotti; S D Aust
Journal:  Lipids       Date:  1992-03       Impact factor: 1.880

3.  Hyperoxic sheep pulmonary microvascular endothelial cells generate free radicals via mitochondrial electron transport.

Authors:  S P Sanders; J L Zweier; P Kuppusamy; S J Harrison; D J Bassett; E W Gabrielson; J T Sylvester
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

4.  Iron supplementation generates hydroxyl radical in vivo. An ESR spin-trapping investigation.

Authors:  M B Kadiiska; M J Burkitt; Q H Xiang; R P Mason
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.